StockSelector.com
  Research, Select, & Monitor Saturday, October 20, 2018 12:41:34 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Genomic Health Inc.$64.40($3.56)(5.24%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Genomic Health Inc. has an overall rank of 1027 out of 7245 stocks based on 10 positive rankings and 10 negative rankings.

Positive Rankings
Estimated EPS Growth
Genomic Health Inc. rank is 4
Up EPS Surprise
Genomic Health Inc. beat the consensus earnings estimate when it last reported quarterly earnings.
90 Day Gain
Genomic Health Inc. rank is 268
SSValue
The StockSelector Value for Genomic Health Inc. is $148.41. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Genomic Health Inc. is ranked 488.
Debt-to-Equity
Genomic Health Inc. rank is 528
Low vPut/Call
Genomic Health Inc. has a low Put/Call ratio of 0.28 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Genomic Health Inc. is ranked 559.
Highest Cash Growth
Genomic Health Inc. rank is 739
Estimated Revenue Growth
Genomic Health Inc. rank is 1080
Historic Revenue Growth
Genomic Health Inc. rank is 1565
Highest Net Margin
Genomic Health Inc. rank is 2528
Negative Rankings
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Genomic Health Inc. is ranked 120.
Price-to-Book
Genomic Health Inc. rank is 336
Negative Past Growth
Genomic Health Inc. rank is 348
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (.76%). Among companies that have had their estimates lowerec within the past month, Genomic Health Inc. is ranked 506.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Genomic Health Inc. is ranked 551.
Price-to-Sales
Genomic Health Inc. rank is 777
High Put/Call
Genomic Health Inc. has a high Put/Call ratio of 0.68 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Genomic Health Inc. is ranked 1432.
Negative ROE
Genomic Health Inc. rank is 1491
Negative ROA
Genomic Health Inc. rank is 1669
10 Day Loss
Genomic Health Inc. rank is 2494







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.